What is Global Acute Kidney Injury Treatment Market?
The Global Acute Kidney Injury Treatment Market is a sector of the healthcare industry that focuses on the treatment of acute kidney injury (AKI). AKI, also known as acute renal failure, is a sudden episode of kidney failure or kidney damage that happens within a few hours or a few days. This market encompasses various treatment methods, including medications, dialysis, and supportive care. The market's value is determined by the demand for these treatments, which is influenced by factors such as the prevalence of AKI, advancements in medical technology, and the availability of healthcare facilities. As of 2023, the market was valued at US$ 1206.1 million and is expected to grow to US$ 1633.3 million by 2030. This growth is a testament to the increasing need for effective AKI treatments worldwide.
Prerenal Acute Kidney Injury, Postrenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury in the Global Acute Kidney Injury Treatment Market:
The Global Acute Kidney Injury Treatment Market is segmented into three categories based on the type of AKI: Prerenal, Postrenal, and Intrinsic Renal. Prerenal AKI is caused by a decrease in blood flow to the kidneys, often due to dehydration or heart failure. Postrenal AKI, on the other hand, is caused by an obstruction in the urinary tract that prevents the kidneys from properly excreting waste. Lastly, Intrinsic Renal AKI is caused by direct damage to the kidneys, such as inflammation or drug toxicity. Each type requires a different treatment approach, which is reflected in the market's offerings. For instance, Prerenal AKI may be treated with fluids or medications to increase blood flow, while Postrenal AKI may require surgery to remove the obstruction. Intrinsic Renal AKI, being the most severe, may require more intensive treatments like dialysis.
Hospitals, Ambulatory Surgical Centers, Others in the Global Acute Kidney Injury Treatment Market:
The Global Acute Kidney Injury Treatment Market is utilized in various healthcare settings, including hospitals, ambulatory surgical centers, and others. Hospitals are the primary users of AKI treatments, as they often have the necessary facilities and personnel to administer intensive treatments like dialysis. Ambulatory surgical centers, while not as equipped as hospitals, can provide treatments for less severe cases of AKI. Other settings, such as clinics and home care, also utilize AKI treatments, albeit to a lesser extent. The use of AKI treatments in these settings is crucial in managing the disease and preventing further complications.
Global Acute Kidney Injury Treatment Market Outlook:
The outlook for the Global Acute Kidney Injury Treatment Market is promising. In 2023, the market was valued at US$ 1206.1 million and is projected to reach US$ 1633.3 million by 2030, reflecting a CAGR of 4.0%. This growth is in line with the overall growth of the global pharmaceutical market, which is estimated to be 1475 billion USD in 2022 and is expected to grow at a CAGR of 5% over the next six years. The chemical drug market, a subset of the pharmaceutical market, is also expected to grow from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. These trends indicate a steady demand for AKI treatments, which is likely to drive the market's growth in the coming years.
| Report Metric | Details |
| Report Name | Acute Kidney Injury Treatment Market |
| Accounted market size in 2023 | US$ 1206.1 million |
| Forecasted market size in 2030 | US$ 1633.3 million |
| CAGR | 4.0% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Angion Biomedica Corp |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
